Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Revenue (2022 - 2025)

Historic Revenue for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $116891.5.

  • InflaRx's Revenue fell 1403.8% to $116891.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $198981.7, marking a year-over-year increase of 788.71%. This contributed to the annual value of $179439.8 for FY2024, which is 16434.86% up from last year.
  • InflaRx's Revenue amounted to $116891.5 in Q3 2025, which was down 1403.8% from $44635.4 recorded in Q2 2025.
  • InflaRx's 5-year Revenue high stood at $8320.2 billion for Q1 2023, and its period low was -$452.02 during Q4 2024.
  • Moreover, its 4-year median value for Revenue was $116891.5 (2025), whereas its average is $691.6 billion.
  • As far as peak fluctuations go, InflaRx's Revenue skyrocketed by 2831779094945.62% in 2023, and later crashed by 11837.76% in 2024.
  • Quarter analysis of 4 years shows InflaRx's Revenue stood at $3.8 million in 2022, then crashed by 99.93% to $2459.6 in 2023, then plummeted by 118.38% to -$452.02 in 2024, then soared by 25960.04% to $116891.5 in 2025.
  • Its last three reported values are $116891.5 in Q3 2025, $44635.4 for Q2 2025, and $37906.8 during Q1 2025.